Impact of COVID-19 on metabolic parameters in patients with type 2 diabetes mellitus

BMC Pulmonary Medicine

Table 1 Clinical and laboratory data of patients in the ‘COVID-19 positive’ group

Variables	Before contracting COVID-19	After contracting COVID-19	P-Value
Weight ^a (kg)	81.8 ± 15	80.9 ± 14.3	0.036
BMI ^a (kg/m2)	28.9 ± 5.3	28.6 ± 5	0.034
Systolic BP (mmHg)	130 ± 20	125 ± 30	0.202
Diastolic BP (mmHg)	75 ± 10	75 ± 10	0.371
MAP ^a (mmHg)	93.4 ± 9.4	92.1 ± 10.3	0.34
FPG (mg/dL)	145 ± 61	135 ± 49	0.1
HbA1C ^a (%)	7.3 ± 1.4	7.4 ± 1.5	0.684
Urea (mg/dL)	28.6 ± 9.5	27.2 ± 7.7	0.196
Cr (mg/dL)	0.94 ± 0.32	0.9 ± 0.2	0.814
eGFR ^a (mL/min/1.7m2)	73.3 ± 16.1	73.7 ± 21.1	0.88
TG (mg/dL)	202 ± 85	148 ± 73	0.001
TC (mg/dL)	170.5 ± 40	159 ± 34.2 ^a	0.028
LDL-C (mg/dL) ^a	86.19 ± 33.12	81.91 ± 27.99	0.34
HDL-C (mg/dL)	47 ± 11.79	47.07 ± 11.26 ^a	0.16
AIP ^a	0.57 ± 0.18	0.52 ± 0.21	0.027
TyG index	4.14 ± 0.22 ^a	4.01 ± 0.27	0.001
TyG-BMI index ^a	119.73 ± 21.12	115.51 ± 21.44	< 0.001

Note: Values were presented as median ± Interquartile Range or number. ^a Values with normal distribution were presented as mean ± Standard deviation. Abbreviations: COVID-19, coronavirus disease 2019; BMI, body mass index; BP, blood pressure; MAP, mean arterial pressure; FPG, fasting plasma glucose; HbA1c, glycated hemoglobin; Cr, creatinine; eGFR, estimated glomerular filtration rate; TG, triglyceride; TC, total cholesterol; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; AIP, atherogenic index of plasma; TyG index, triglyceride–glucose index; TyG-BMI, triglyceride-glucose body mass index

ISSN: 1471-2466